Literature DB >> 35916966

Correlates of HIV Testing across the lifespan - adolescence through later adulthood - among sexual minority men in the US who are not on PrEP.

Trey V Dellucci1,2, S Scott Jones1, Christel Adhemar1, Sarah W Feldstein Ewing3, Travis I Lovejoy4,5, Tyrel J Starks6,7.   

Abstract

Regular HIV testing is an essential component of the HIV prevention and care cascade. Sexual minority males (SMM) account for most new HIV infections in the US and testing rates among SMM vary substantially across the lifespan. Research has largely overlooked the developmental context of HIV testing. The current study compared correlates of HIV testing among adolescents (aged 13-17; n = 1,641), emerging adults (aged 18-29; n = 50,483), early adults (aged 30-39; n = 25,830), middle adults (aged 40-64; n = 25,326), and late adults (65 and older; n = 1,452) who were recruited online. Overall, HIV testing rates were lowest among adolescent SMM. Having condomless anal sex in the past 3-months was a consistentpredictor of HIV testing across all age cohorts.The association between relationship status and frequency of HIV testing varied across ages. Being in a non-monogamous relationship (versus single) was associated with more frequent HIV testing among adolescent and emerging adult SMM , while being in a monogamous relationship (versus single) was associated with lower odds of HIV testing among early, middle, and late adults.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  HIV testing; LGBT; life span; sexual health; sexual minority

Year:  2022        PMID: 35916966     DOI: 10.1007/s10865-022-00341-2

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  1 in total

1.  Testing the drug use and condomless anal sex link among sexual minority men: The predictive utility of marijuana and interactions with relationship status.

Authors:  Tyrel J Starks; S Scott Jones; Kory Kyre; Gabriel Robles; Demetria Cain; Ruben Jimenez; Rob Stephenson; Patrick S Sullivan
Journal:  Drug Alcohol Depend       Date:  2020-09-28       Impact factor: 4.492

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.